318 related articles for article (PubMed ID: 16142516)
1. Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children.
Gilbert N; Luther YC; Miera O; Nagdyman N; Ewert P; Berger F; Lange PE; Schulze-Neick I
Z Kardiol; 2005 Sep; 94(9):570-4. PubMed ID: 16142516
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Sompradikul S
J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
[TBL] [Abstract][Full Text] [Related]
4. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease.
Ibrahim R; Granton JT; Mehta S
Can Respir J; 2006; 13(8):415-20. PubMed ID: 17149459
[TBL] [Abstract][Full Text] [Related]
5. [Outcome of oral bosentan in children with congenital heart disease associated pulmonary arterial hypertension].
Xu ZM; Zhu LM; Cai XM; Ji G; Liu JF; Su ZK
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2106-9. PubMed ID: 20058613
[TBL] [Abstract][Full Text] [Related]
6. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.
Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic effects of single oral dose of bosentan in patients with pulmonary arterial hypertension related to congenital heart disease.
Ajami G; Ahmadipour M; Amoozgar H; Bourzoee M; Cheriki S; Shakiba AM; Edraki MR
Congenit Heart Dis; 2014; 9(4):343-8. PubMed ID: 25247216
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
Monfredi O; Griffiths L; Clarke B; Mahadevan VS
Am J Cardiol; 2011 Nov; 108(10):1483-8. PubMed ID: 21943933
[TBL] [Abstract][Full Text] [Related]
9. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
10. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery.
Hirono K; Yoshimura N; Taguchi M; Watanabe K; Nakamura T; Ichida F; Miyawaki T
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):346-51. PubMed ID: 20434177
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term bosentan in children with pulmonary arterial hypertension.
Rosenzweig EB; Ivy DD; Widlitz A; Doran A; Claussen LR; Yung D; Abman SH; Morganti A; Nguyen N; Barst RJ
J Am Coll Cardiol; 2005 Aug; 46(4):697-704. PubMed ID: 16098438
[TBL] [Abstract][Full Text] [Related]
12. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.
Fine N; Dias B; Shoemaker G; Mehta S
Can J Cardiol; 2009 Mar; 25(3):e63-8. PubMed ID: 19279988
[TBL] [Abstract][Full Text] [Related]
13. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease.
Schuuring MJ; Bouma BJ; Cordina R; Gatzoulis MA; Budts W; Mullen MP; Vis JC; Celermajer D; Mulder BJ
Int J Cardiol; 2013 Mar; 164(1):106-10. PubMed ID: 21763017
[TBL] [Abstract][Full Text] [Related]
14. Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy.
Schulze-Neick I; Gilbert N; Ewert R; Witt C; Gruenig E; Enke B; Borst MM; Lange PE; Hoeper MM
Am Heart J; 2005 Oct; 150(4):716. PubMed ID: 16209972
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21.
Kermeen FD; Franks C; O'Brien K; Seale H; Hall K; McNeil K; Radford D
Heart Lung Circ; 2010 Oct; 19(10):595-600. PubMed ID: 20728407
[TBL] [Abstract][Full Text] [Related]
17. [Effects of bosentan in treatment of pulmonary arterial hypertension: a pilot study of 21 patients].
Jing ZC; Xu XQ; Ma CR; Wang Y; Wu Y; Jiang X; Pan L; Yang YJ
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2136-9. PubMed ID: 19080476
[TBL] [Abstract][Full Text] [Related]
18. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.
Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
Heart; 2005 Nov; 91(11):1447-52. PubMed ID: 15761050
[TBL] [Abstract][Full Text] [Related]
19. Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program.
Beghetti M; Hoeper MM; Kiely DG; Carlsen J; Schwierin B; Segal ES; Humbert M
Pediatr Res; 2008 Aug; 64(2):200-4. PubMed ID: 18414142
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease.
Baptista R; Castro G; da Silva AM; Monteiro P; Providência LA
Rev Port Cardiol; 2013 Feb; 32(2):123-9. PubMed ID: 23351920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
